Phillips, P, Johnson, S. Drug and alcohol misuse among in-patients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull
2003; 27: 217–20.
Weaver, T, Madden, P, Charles, V, Stimson, G, Renton, A, Tyrer, P, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry
2003; 183: 304–13.
Van Mastrigt, S, Addington, J, Addington, D. Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol
2004; 39: 69–72.
Barnes, TRE, Mutsatsa, SH, Hutton, SB, Watt, HC, Joyce, EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry
2006; 188: 237–42.
Mauri, MC, Vovonteri, LS, DeGaspari, IF. Substance abuse in first episode schizophrenic patients: a retrospective study. Clin Pract Epidemiol Ment Health
2006; 2: 4–11.
Barnett, JH, Werners, U, Secher, SM, Hill, KE, Brazil, R, Masson, K, et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry
2007; 190: 515–20.
Wade, D, Harrigan, S, Edwards, J, Burgess, PM, Whelan, G, McGorry, PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry
2006; 189: 229–43.
Kessler, RC, Berglund, P, Demler, O, Jin, R, Merikangas, KR, Walters, EE. Lifetime prevalence and age-of-onset of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry
2005; 62: 593–602.
Volkov, ND. Substance use disorders in schizophrenia – clinical implications of comorbidity. Schizophr Bull
2009; 35: 469–72.
Caton, CLM, Samet, S, Hasin, DH. When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders. J Psychiatr Pract
2000; 6: 256–66.
Foti, DJ, Kotov, R, Guey, LT, Bromet, EJ. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry
2010; 167: 987–93.
Addington, J, Addington, D. Effect of substance misuse in early psychosis. Br J Psychiatry
1998; 172 (suppl 33): s134–6.
Turkington, A, Mulholland, CC, Rushe, TM, Anderson, R, McCaul, R, Barrett, SL, et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry
2009; 195: 242–8.
Schuckit, MA. Drug and Alcohol Abuse, 3rd edn. Plenum Publishing, 1989.
Satel, SL, Edell, WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry
1991; 148: 1708–11.
McLellan, AT, Woody, GE, O'Brien, CP. Development of psychiatric illness in drug abusers: possible role of drug preference. N Engl J Med
1979; 301: 1310–4.
Angrist, B. Amphetamine psychosis: clinical variations of a syndrome. In Amphetamine and its Analogs (eds Cho, AK, Segal, DS): 387–414. Academic Press, 1994.
Bowers, MB, Swigar, ME. Vulnerability to psychosis associated with hallucinogen use. Psychiatry Res
1983; 9: 91–7.
D'Souza, DC, Perry, E, MacDougall, L, Ammerman, Y, Cooper, T, Wu, YT, et al. The psychotomimetic effect of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacol
2004; 29: 1558–72.
Koskinen, J, Lohonen, J, Koponen, H, Isohanni, M, Miettunen, J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull
2010; 36: 1115–30.
Minozzi, S, Davoli, M, Bargagli, AM, Amato, L, Vecchi, S, Perucci, CA. An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev
2010; 29: 304–17.
Arseneault, L, Cannon, M, Witton, J, Murray, RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry
2004; 184: 110–7.
Semple, DM, McIntosh, AM, Lawrie, SM. Cannabis as a risk factor for psychosis; systematic review. J Psychopharmacol
2005; 19: 187–94.
Henquet, C, Murry, R, Linszen, D, van Os, J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull
2005; 31: 608–12.
Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, et al. Cannabis use and the risk of psychotic or affective mental health outcomes: a systematic review. Lancet
2007; 370: 319–28.
McGrath, J, Welham, J, Scott, J, Varghese, D, Degenhardt, L, Hayatbakhsh, MR, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry
2010; 67: 440–7.
Di Forti, M, Morgan, C, Dazzan, P, Pariante, C, Mondelli, V, Marques, TR, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry
2009; 195: 448–91.
Ley, A, Jeffery, D, Ruiz, J, McLaren, S, Gillespie, C. Underdetection of comorbid drug use at acute psychiatric admission. Psychiatr Bull
2002; 26: 248–51.
Caton, CLM, Hasin, DS, Shrout, PE, Drake, RE, Dominguez, B, First, MB, et al. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br J Psychiatry
2007; 190: 105–11.
Mathias, S, Lubman, DI, Hides, L. Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry
2008; 69: 358–67.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision (DSM-IV-TR). APA, 2000.
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry
2005; 62: 975–83.
Crebbin, K, Mitford, E, Paxton, R, Turkington, D. First episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. Soc Psychiatry Psychiatr Epidemiol
2009; 44: 710–5.
Dawson, R, Green, AI, Drake, RE, Lavori, PW, McGlashan, TH, Schanzer, B. An adaptive treatment strategy paradigm for longitudinal treatment research using substance-induced psychosis as an example. Psychopharmacol Bull
2008; 41: 51–67.
Drake, RE, Caton, CLM, Xie, H, Hsu, E, Gorroochurn, P, Samet, S, et al. A prospective 2-year study of emergency department patients with early-phase primary psychosis or substance-induced psychosis. Am J Psychiatry
2011; 31 Mar (doi: 10.1176/appi.ajp.2011.10071051).
Schanzer, MB, First, MB, Dominguez, B, Hasin, DS, Caton, CLM. Diagnosing psychotic disorders in the emergency department in the context of substance use. Psychiatr Serv
2006; 57: 1468–73.
Hall, W, Degenhardt, L. What are the policy implications of the evidence on cannabis and psychosis?
Can J Psychiatry
2006; 51: 566–74.
Miller, WR, Rollnick, S.
Motivational Interviewing: Preparing People for Change. Guilford Press, 2002.
Burns, T, Firn, M.
Assertive Outreach in Mental Health: A Manual for Practitioners. Oxford University Press, 2002.
Tyrer, P, Weaver, T. Desperately seeking solutions: the search for appropriate treatment for comorbid substance misuse and psychosis. Psychiatr Bull
2004; 28: 1–2.
Johnson, S, Thornicroft, G, Afuwape, S, Leese, M, White, IR, Hughes, E, et al. Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study). Cluster randomised trial. Br J Psychiatry
2007; 191: 451–2.